• The Ticker
  • Message Boards
  • Jobs
  • Medtech[y] Shop
  • 
  • 
  • 
  • View
  • ALL
  • Biotech
  • Medical Device
  • Robotic Surgery
  • Medical Device Sales
  • Medtechy Deals
  • Future of Healthcare
  • Healthcare Fraud
  • Hospitals

Join Our Mailing List Today

Amarin Takes Proactive Steps to Support Public Health Priorities

Posted in Biotech by Medtech[y] Staff

March 15, 2020 • 2 min read

DUBLIN, Ireland and BRIDGEWATER, N.J., March 15, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a leader in preventative cardiovascular risk reduction therapy, today announced actions in support of public health initiatives to combat ...

Teladoc Health Sees Daily Virtual Medical Visits Up 50% in Past Week

Posted in Future of Healthcare by Medtech[y] Staff

March 14, 2020 • 2 min read

PURCHASE, NY, March 13, 2020 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today shared that the company is experiencing unprecedented daily visit volume in the United States as the novel coronavirus continues to...

Advaxis Reports First Quarter Ended January 31, 2020 Financial Results and Provides a Pipeline Update

Posted in Biotech by Medtech[y] Staff

March 13, 2020 • 2 min read

PRINCETON, N.J., March 13, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced an update on its clinical pipeline and...

La Jolla Pharmaceutical Company to Provide GIAPREZA (Angiotensin II) in Italy for Compassionate Use in Patients with Septic Shock Associated with COVID-19

Posted in Biotech by Medtech[y] Staff

March 13, 2020 • 2 min read

SAN DIEGO, March 13, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseas...

PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS

Posted in Biotech by Medtech[y] Staff

March 13, 2020 • 2 min read

NEW YORK, March 13, 2020 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced financial results for the fourth quarter and full-year 2019....

Predictive Oncology Launches New AI Platform for Vaccine and Drug Development Targeting Coronaviruses and Acute Respiratory Syndromes (COVID-19, MERS, and SARS)

Posted in Biotech by Medtech[y] Staff

March 12, 2020 • 2 min read

MINNEAPOLIS, March 12, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“POAI” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announ...

SCYNEXIS Reports Full Year 2019 Financial Results and Provides Company Update

Posted in Biotech by Medtech[y] Staff

March 11, 2020 • 2 min read

JERSEY CITY, N.J., March 11, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug resistant infections, reported financial results for the ...

Aduro Biotech Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

Posted in Biotech by Medtech[y] Staff

March 09, 2020 • 2 min read

BERKELEY, Calif., March 09, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Liga...

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

Posted in Medical Device by Medtech[y] Staff

March 09, 2020 • 2 min read

SANTA CLARA, Calif., March 09, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter and full year en...

Myovant Sciences Submits Marketing Authorization Application to the European Medicines Agency for Relugolix Combination Tablet for the Treatment of Women with Uterine Fibroids

Posted in Biotech by Medtech[y] Staff

March 09, 2020 • 2 min read

BASEL, Switzerland, March 09, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer, today announced the submission of a Marketing Authorization...

SUBMIT A TIP

Are you aware of fraud occurring at your workplace or previous place of employment?

Speak up, speak out, do the right thing.

REPORT HEALTHCARE FRAUD

TOP BOARD THREADS
  • Amarin EVAPORATE Study Results
    Amarin Message Board board
  • How do I get into Medical Device Sales?
    Medical Sales General Discussion board
  • What are the Best Biotech Stocks?
    Pharma/Biotech General Discussion board
  • FiercePharma's Top Pharma Companies in the World
    Pharma/Biotech Message Board board
  • Baker Brothers Advisors
    Pharma/Biotech General Discussion board
  • Will the FDA Approval Expanded Label for Vascepa?
    Amarin Message Board board
  • Is Amgen Looking to Acquire MannKind
    MannKind Message Board board
  • MedReps.com Jobs
    Medical Sales General Discussion board
  • Zimmer Biomet Layoffs
    Zimmer Biomet Message Board board
  • Medical Device Reps Back in the OR after COVID-19
    Medical Device Sales General Discussion board
  • READ MORE ON THE BOARDS

FEATURED JOBS
  • Medical Affairs Program Specialist
  • VIEW MORE JOBS

  • First Page
  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page
  • Last Page

Developed by medical sales professionals for medical sales professionals.

 •  @medtechy •  medtechy

copyright Medtechy Inc. ⋅ Report A Tip ⋅ Terms of Use ⋅ Privacy Policy ⋅ DMCA Policy ⋅ Removal Policy ⋅ [email protected]